img

Global Furosemide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Furosemide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Furosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
Furosemide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Furosemide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Furosemide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Furosemide key manufacturers include Sanofi Aventis, US Pharm Holdings, Mylan, Sandoz, Hospira, West-Ward Pharms, Ivax Sub Teva Pharms, Emcure Pharms and Sun Pharm Inds, etc. Sanofi Aventis, US Pharm Holdings, Mylan are top 3 players and held % sales share in total in 2022.
Furosemide can be divided into Injection, Solution and Tablet,, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Furosemide is widely used in various fields, such as Hospital, Pharmacy, Clinics and Others, etc. Hospital provides greatest supports to the Furosemide industry development. In 2022, global % sales of Furosemide went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Furosemide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi Aventis
US Pharm Holdings
Mylan
Sandoz
Hospira
West-Ward Pharms
Ivax Sub Teva Pharms
Emcure Pharms
Sun Pharm Inds
Segment by Type
Injection
Solution
Tablet

Segment by Application


Hospital
Pharmacy
Clinics
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Furosemide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Furosemide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Furosemide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Furosemide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Furosemide introduction, etc. Furosemide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Furosemide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Furosemide Market Overview
1.1 Furosemide Product Overview
1.2 Furosemide Market Segment by Type
1.2.1 Injection
1.2.2 Solution
1.2.3 Tablet
1.3 Global Furosemide Market Size by Type
1.3.1 Global Furosemide Market Size Overview by Type (2018-2034)
1.3.2 Global Furosemide Historic Market Size Review by Type (2018-2024)
1.3.3 Global Furosemide Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Furosemide Sales Breakdown by Type (2018-2024)
1.4.2 Europe Furosemide Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Furosemide Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Furosemide Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Furosemide Sales Breakdown by Type (2018-2024)
2 Global Furosemide Market Competition by Company
2.1 Global Top Players by Furosemide Sales (2018-2024)
2.2 Global Top Players by Furosemide Revenue (2018-2024)
2.3 Global Top Players by Furosemide Price (2018-2024)
2.4 Global Top Manufacturers Furosemide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Furosemide Market Competitive Situation and Trends
2.5.1 Furosemide Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Furosemide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Furosemide as of 2022)
2.7 Date of Key Manufacturers Enter into Furosemide Market
2.8 Key Manufacturers Furosemide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Furosemide Status and Outlook by Region
3.1 Global Furosemide Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Furosemide Historic Market Size by Region
3.2.1 Global Furosemide Sales in Volume by Region (2018-2024)
3.2.2 Global Furosemide Sales in Value by Region (2018-2024)
3.2.3 Global Furosemide Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Furosemide Forecasted Market Size by Region
3.3.1 Global Furosemide Sales in Volume by Region (2024-2034)
3.3.2 Global Furosemide Sales in Value by Region (2024-2034)
3.3.3 Global Furosemide Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Furosemide by Application
4.1 Furosemide Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Clinics
4.1.4 Others
4.2 Global Furosemide Market Size by Application
4.2.1 Global Furosemide Market Size Overview by Application (2018-2034)
4.2.2 Global Furosemide Historic Market Size Review by Application (2018-2024)
4.2.3 Global Furosemide Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Furosemide Sales Breakdown by Application (2018-2024)
4.3.2 Europe Furosemide Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Furosemide Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Furosemide Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Furosemide Sales Breakdown by Application (2018-2024)
5 North America Furosemide by Country
5.1 North America Furosemide Historic Market Size by Country
5.1.1 North America Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Furosemide Sales in Volume by Country (2018-2024)
5.1.3 North America Furosemide Sales in Value by Country (2018-2024)
5.2 North America Furosemide Forecasted Market Size by Country
5.2.1 North America Furosemide Sales in Volume by Country (2024-2034)
5.2.2 North America Furosemide Sales in Value by Country (2024-2034)
6 Europe Furosemide by Country
6.1 Europe Furosemide Historic Market Size by Country
6.1.1 Europe Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Furosemide Sales in Volume by Country (2018-2024)
6.1.3 Europe Furosemide Sales in Value by Country (2018-2024)
6.2 Europe Furosemide Forecasted Market Size by Country
6.2.1 Europe Furosemide Sales in Volume by Country (2024-2034)
6.2.2 Europe Furosemide Sales in Value by Country (2024-2034)
7 Asia-Pacific Furosemide by Region
7.1 Asia-Pacific Furosemide Historic Market Size by Region
7.1.1 Asia-Pacific Furosemide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Furosemide Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Furosemide Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Furosemide Forecasted Market Size by Region
7.2.1 Asia-Pacific Furosemide Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Furosemide Sales in Value by Region (2024-2034)
8 Latin America Furosemide by Country
8.1 Latin America Furosemide Historic Market Size by Country
8.1.1 Latin America Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Furosemide Sales in Volume by Country (2018-2024)
8.1.3 Latin America Furosemide Sales in Value by Country (2018-2024)
8.2 Latin America Furosemide Forecasted Market Size by Country
8.2.1 Latin America Furosemide Sales in Volume by Country (2024-2034)
8.2.2 Latin America Furosemide Sales in Value by Country (2024-2034)
9 Middle East and Africa Furosemide by Country
9.1 Middle East and Africa Furosemide Historic Market Size by Country
9.1.1 Middle East and Africa Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Furosemide Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Furosemide Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Furosemide Forecasted Market Size by Country
9.2.1 Middle East and Africa Furosemide Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Furosemide Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi Aventis
10.1.1 Sanofi Aventis Company Information
10.1.2 Sanofi Aventis Introduction and Business Overview
10.1.3 Sanofi Aventis Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Aventis Furosemide Products Offered
10.1.5 Sanofi Aventis Recent Development
10.2 US Pharm Holdings
10.2.1 US Pharm Holdings Company Information
10.2.2 US Pharm Holdings Introduction and Business Overview
10.2.3 US Pharm Holdings Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.2.4 US Pharm Holdings Furosemide Products Offered
10.2.5 US Pharm Holdings Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mylan Furosemide Products Offered
10.3.5 Mylan Recent Development
10.4 Sandoz
10.4.1 Sandoz Company Information
10.4.2 Sandoz Introduction and Business Overview
10.4.3 Sandoz Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sandoz Furosemide Products Offered
10.4.5 Sandoz Recent Development
10.5 Hospira
10.5.1 Hospira Company Information
10.5.2 Hospira Introduction and Business Overview
10.5.3 Hospira Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Hospira Furosemide Products Offered
10.5.5 Hospira Recent Development
10.6 West-Ward Pharms
10.6.1 West-Ward Pharms Company Information
10.6.2 West-Ward Pharms Introduction and Business Overview
10.6.3 West-Ward Pharms Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.6.4 West-Ward Pharms Furosemide Products Offered
10.6.5 West-Ward Pharms Recent Development
10.7 Ivax Sub Teva Pharms
10.7.1 Ivax Sub Teva Pharms Company Information
10.7.2 Ivax Sub Teva Pharms Introduction and Business Overview
10.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ivax Sub Teva Pharms Furosemide Products Offered
10.7.5 Ivax Sub Teva Pharms Recent Development
10.8 Emcure Pharms
10.8.1 Emcure Pharms Company Information
10.8.2 Emcure Pharms Introduction and Business Overview
10.8.3 Emcure Pharms Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Emcure Pharms Furosemide Products Offered
10.8.5 Emcure Pharms Recent Development
10.9 Sun Pharm Inds
10.9.1 Sun Pharm Inds Company Information
10.9.2 Sun Pharm Inds Introduction and Business Overview
10.9.3 Sun Pharm Inds Furosemide Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sun Pharm Inds Furosemide Products Offered
10.9.5 Sun Pharm Inds Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Furosemide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Furosemide Industrial Chain Analysis
11.4 Furosemide Market Dynamics
11.4.1 Furosemide Industry Trends
11.4.2 Furosemide Market Drivers
11.4.3 Furosemide Market Challenges
11.4.4 Furosemide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Furosemide Distributors
12.3 Furosemide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Injection
Table 2. Major Company of Solution
Table 3. Major Company of Tablet
Table 4. Global Furosemide Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Furosemide Sales by Type (2018-2024) & (MT)
Table 6. Global Furosemide Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Furosemide Sales by Type (2018-2024) & (US& Million)
Table 8. Global Furosemide Market Share in Value by Type (2018-2024)
Table 9. Global Furosemide Price by Type (2018-2024) & (USD/Kg)
Table 10. Global Furosemide Sales by Type (2024-2034) & (MT)
Table 11. Global Furosemide Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Furosemide Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Furosemide Sales Market Share in Value by Type (2024-2034)
Table 14. Global Furosemide Price by Type (2024-2034) & (USD/Kg)
Table 15. North America Furosemide Sales by Type (2018-2024) & (MT)
Table 16. North America Furosemide Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Furosemide Sales (MT) by Type (2018-2024)
Table 18. Europe Furosemide Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Furosemide Sales (MT) by Type (2018-2024)
Table 20. Asia-Pacific Furosemide Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Furosemide Sales (MT) by Type (2018-2024)
Table 22. Latin America Furosemide Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Furosemide Sales (MT) by Type (2018-2024)
Table 24. Middle East and Africa Furosemide Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Furosemide Sales by Company (2018-2024) & (MT)
Table 26. Global Furosemide Sales Share by Company (2018-2024)
Table 27. Global Furosemide Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Furosemide Revenue Share by Company (2018-2024)
Table 29. Global Market Furosemide Price by Company (2018-2024) & (USD/Kg)
Table 30. Global Furosemide Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Furosemide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Furosemide as of 2022)
Table 33. Date of Key Manufacturers Enter into Furosemide Market
Table 34. Key Manufacturers Furosemide Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Furosemide Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Furosemide Sales by Region (2018-2024) & (MT)
Table 38. Global Furosemide Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Furosemide Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Furosemide Sales Market Share in Value by Region (2018-2024)
Table 41. Global Furosemide Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 42. Global Furosemide Sales by Region (2024-2034) & (MT)
Table 43. Global Furosemide Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Furosemide Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Furosemide Sales Market Share in Value by Region (2024-2034)
Table 46. Global Furosemide Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 47. Global Furosemide Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Furosemide Sales by Application (2018-2024) & (MT)
Table 49. Global Furosemide Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Furosemide Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Furosemide Sales Market Share in Value by Application (2018-2024)
Table 52. Global Furosemide Price by Application (2018-2024) & (USD/Kg)
Table 53. Global Furosemide Sales by Application (2024-2034) & (MT)
Table 54. Global Furosemide Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Furosemide Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Furosemide Sales Market Share in Value by Application (2024-2034)
Table 57. Global Furosemide Price by Application (2024-2034) & (USD/Kg)
Table 58. North America Furosemide Sales by Application (2018-2024) (MT)
Table 59. North America Furosemide Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Furosemide Sales by Application (2018-2024) (MT)
Table 61. Europe Furosemide Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Furosemide Sales by Application (2018-2024) (MT)
Table 63. Asia-Pacific Furosemide Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Furosemide Sales by Application (2018-2024) (MT)
Table 65. Latin America Furosemide Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Furosemide Sales by Application (2018-2024) (MT)
Table 67. Middle East and Africa Furosemide Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Furosemide Sales by Country (2018-2024) & (MT)
Table 69. North America Furosemide Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Furosemide Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Furosemide Sales Market Share in Value by Country (2018-2024)
Table 72. North America Furosemide Sales by Country (2024-2034) & (MT)
Table 73. North America Furosemide Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Furosemide Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Furosemide Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Furosemide Sales by Country (2018-2024) & (MT)
Table 77. Europe Furosemide Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Furosemide Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Furosemide Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Furosemide Sales by Country (2024-2034) & (MT)
Table 81. Europe Furosemide Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Furosemide Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Furosemide Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Furosemide Sales by Region (2018-2024) & (MT)
Table 85. Asia-Pacific Furosemide Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Furosemide Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Furosemide Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Furosemide Sales by Region (2024-2034) & (MT)
Table 89. Asia-Pacific Furosemide Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Furosemide Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Furosemide Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Furosemide Sales by Country (2018-2024) & (MT)
Table 93. Latin America Furosemide Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Furosemide Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Furosemide Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Furosemide Sales by Country (2024-2034) & (MT)
Table 97. Latin America Furosemide Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Furosemide Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Furosemide Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Furosemide Sales by Country (2018-2024) & (MT)
Table 101. Middle East and Africa Furosemide Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Furosemide Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Furosemide Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Furosemide Sales by Country (2024-2034) & (MT)
Table 105. Middle East and Africa Furosemide Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Furosemide Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Furosemide Sales Market Share in Value by Country (2024-2034)
Table 108. Sanofi Aventis Company Information
Table 109. Sanofi Aventis Introduction and Business Overview
Table 110. Sanofi Aventis Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 111. Sanofi Aventis Furosemide Product
Table 112. Sanofi Aventis Recent Development
Table 113. US Pharm Holdings Company Information
Table 114. US Pharm Holdings Introduction and Business Overview
Table 115. US Pharm Holdings Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 116. US Pharm Holdings Furosemide Product
Table 117. US Pharm Holdings Recent Development
Table 118. Mylan Company Information
Table 119. Mylan Introduction and Business Overview
Table 120. Mylan Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 121. Mylan Furosemide Product
Table 122. Mylan Recent Development
Table 123. Sandoz Company Information
Table 124. Sandoz Introduction and Business Overview
Table 125. Sandoz Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 126. Sandoz Furosemide Product
Table 127. Sandoz Recent Development
Table 128. Hospira Company Information
Table 129. Hospira Introduction and Business Overview
Table 130. Hospira Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 131. Hospira Furosemide Product
Table 132. Hospira Recent Development
Table 133. West-Ward Pharms Company Information
Table 134. West-Ward Pharms Introduction and Business Overview
Table 135. West-Ward Pharms Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 136. West-Ward Pharms Furosemide Product
Table 137. West-Ward Pharms Recent Development
Table 138. Ivax Sub Teva Pharms Company Information
Table 139. Ivax Sub Teva Pharms Introduction and Business Overview
Table 140. Ivax Sub Teva Pharms Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 141. Ivax Sub Teva Pharms Furosemide Product
Table 142. Ivax Sub Teva Pharms Recent Development
Table 143. Emcure Pharms Company Information
Table 144. Emcure Pharms Introduction and Business Overview
Table 145. Emcure Pharms Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 146. Emcure Pharms Furosemide Product
Table 147. Emcure Pharms Recent Development
Table 148. Sun Pharm Inds Company Information
Table 149. Sun Pharm Inds Introduction and Business Overview
Table 150. Sun Pharm Inds Furosemide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 151. Sun Pharm Inds Furosemide Product
Table 152. Sun Pharm Inds Recent Development
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Furosemide Market Trends
Table 156. Furosemide Market Drivers
Table 157. Furosemide Market Challenges
Table 158. Furosemide Market Restraints
Table 159. Furosemide Distributors List
Table 160. Furosemide Downstream Customers
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Furosemide Product Picture
Figure 2. Global Furosemide Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Furosemide Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Furosemide Sales Status and Outlook (2018-2034) & (MT)
Figure 5. Product Picture of Injection
Figure 6. Global Injection Sales YoY Growth (2018-2034) & (MT)
Figure 7. Product Picture of Solution
Figure 8. Global Solution Sales YoY Growth (2018-2034) & (MT)
Figure 9. Product Picture of Tablet
Figure 10. Global Tablet Sales YoY Growth (2018-2034) & (MT)
Figure 11. Global Furosemide Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Furosemide Sales Market Share by Type in 2022 & 2034
Figure 13. North America Furosemide Sales Market Share in Volume by Type in 2022
Figure 14. North America Furosemide Sales Market Share in Value by Type in 2022
Figure 15. Europe Furosemide Sales Market Share in Volume by Type in 2022
Figure 16. Europe Furosemide Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Furosemide Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Furosemide Sales Market Share in Value by Type in 2022
Figure 19. Latin America Furosemide Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Furosemide Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Furosemide Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Furosemide Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Furosemide Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Furosemide Revenue in 2022
Figure 25. Furosemide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (MT)
Figure 28. Product Picture of Pharmacy
Figure 29. Global Pharmacy Sales YoY Growth (2018-2034) & (MT)
Figure 30. Product Picture of Clinics
Figure 31. Global Clinics Sales YoY Growth (2018-2034) & (MT)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (MT)
Figure 34. Global Furosemide Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Furosemide Sales Market Share by Application in 2022 & 2034
Figure 36. North America Furosemide Sales Market Share in Volume by Application in 2022
Figure 37. North America Furosemide Sales Market Share in Value by Application in 2022
Figure 38. Europe Furosemide Sales Market Share in Volume by Application in 2022
Figure 39. Europe Furosemide Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Furosemide Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Furosemide Sales Market Share in Value by Application in 2022
Figure 42. Latin America Furosemide Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Furosemide Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Furosemide Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Furosemide Manufacturing Cost Structure
Figure 47. Furosemide Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries